chr7-21561159-C-T
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001277115.2(DNAH11):c.971C>T(p.Ala324Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00022 in 1,590,874 control chromosomes in the GnomAD database, including 2 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001277115.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DNAH11 | NM_001277115.2 | c.971C>T | p.Ala324Val | missense_variant | 5/82 | ENST00000409508.8 | NP_001264044.1 | |
LOC105375183 | XR_007060247.1 | n.283-919G>A | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DNAH11 | ENST00000409508.8 | c.971C>T | p.Ala324Val | missense_variant | 5/82 | 5 | NM_001277115.2 | ENSP00000475939 | P1 | |
DNAH11 | ENST00000483691.1 | n.167C>T | non_coding_transcript_exon_variant | 2/2 | 3 | |||||
DNAH11 | ENST00000496218.1 | n.69C>T | non_coding_transcript_exon_variant | 1/2 | 2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152124Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000343 AC: 73AN: 212986Hom.: 1 AF XY: 0.000377 AC XY: 43AN XY: 114078
GnomAD4 exome AF: 0.000228 AC: 328AN: 1438632Hom.: 2 Cov.: 29 AF XY: 0.000220 AC XY: 157AN XY: 713230
GnomAD4 genome AF: 0.000145 AC: 22AN: 152242Hom.: 0 Cov.: 32 AF XY: 0.000188 AC XY: 14AN XY: 74436
ClinVar
Submissions by phenotype
Primary ciliary dyskinesia Benign:2
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 30, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
DNAH11-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at